

Clear paths through a rare diagnosis
When facing an ultra-rare diagnosis like blue nevus melanoma, authoritative information is your strongest anchor. We translate complex molecular oncology into clear, actionable steps for you and your family.


Understanding GNAQ and GNA11
Blue nevus melanoma is driven by specific somatic mutations. Our validated guides break down the science of molecular oncology, explaining how these genetic markers influence your care plan and therapeutic options.
Developed in collaboration with leading ocular and cutaneous oncology clinicians, these resources provide the exact vocabulary you need to navigate clinical consultations and discuss treatment options with confidence.
Navigating your medical network
Finding the right specialists is critical for rare diseases. We bridge the gap between patients, families, and specialized ocular and cutaneous oncology clinicians globally.
Oncology Directory
Clinical Trials
Patient Registry
Access our curated list of global clinicians specializing in rare melanomas.
Identify active academic medical centers hosting GNAQ/GNA11 research.
Join the global registry to accelerate drug discovery and trials.
Finding a community that understands GNAQ/GNA11 mutations changed everything. I went from feeling completely isolated to having a shared clinical roadmap.
Sarah M., Patient & Foundation Advocate
Your clinical roadmap
Download our comprehensive patient guide today to access validated clinical resources, or connect with our support network to speak with others who understand this diagnosis.
Location
52 Monte Vista Ave Atherton, CA, 94027-5431 United States
CONTACT US
650-322-1866
info@bluenevus.com
EIN: 33-1267965
© 2026 Blue Nevus Melanoma Foundation-Patient-founded. Science-driven. Established 2024.
GNAQ/GNA11 RESEARCH
